PAR DRUGS AND CHEM LTD (PAR) financials

PAR DRUGS AND CHEM LTD (PAR) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals[1]

Market Cap: ₹135Cr.
Current Price: ₹110
Stock P/E: 9.30
ROE: 9.95%
ROCE: 14.6%
Book Value: ₹91.0
Dividend Yield: 0.00%
52W High / Low: ₹180/78.0

In Jun 2026, PAR DRUGS AND CHEM LTD (PAR) reported sales ₹31.28 Cr and net profit ₹4.71 Cr.

Annual TTM: sales ₹109 Cr, net profit ₹14 Cr.

Shareholding: Promoters 73.41% (Sep 2026), FIIs 0.00% (Sep 2026), DIIs 0.09% (Sep 2026), Public 26.51% (Sep 2026), No. of Shareholders 12,672% (Sep 2026).

PAR quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	34.66	21.38	22.33	26.05	28.66	29.34	19.61	31.28
Expenses	23.25	19.95	19.90	22.49	22.60	23.29	18.17	24.91
Operating Profit	11.41	1.43	2.43	3.56	6.06	6.05	1.44	6.37
OPM %	32.92%	6.69%	10.88%	13.67%	21.14%	20.62%	7.34%	20.36%
Other Income	1.02	0.27	0.79	1.84	0.48	1.33	0.36	0.94
Interest	0.03	0.01	0.02	0.02	0.05	0.01	0.04	0.02
Depreciation	0.91	0.91	0.92	0.90	0.94	0.93	0.93	0.96
Profit before tax	11.49	0.78	2.28	4.48	5.55	6.44	0.83	6.33
Tax %	25.15%	24.36%	27.63%	25.67%	25.59%	25.47%	-3.61%	25.59%
Net Profit	8.60	0.58	1.65	3.33	4.13	4.80	0.85	4.71
EPS in Rs	6.99	0.47	1.34	2.71	3.36	3.90	0.69	3.83
Raw PDF	—	—	—	—	—	—	—	—

PAR profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	56	61	75	96	96	101	104	109
Expenses	46	45	59	78	73	81	87	89
Operating Profit	9	16	16	18	23	20	17	20
OPM %	17%	26%	22%	19%	24%	19%	17%	18%
Other Income	0	2	0	0	0	2	4	3
Interest	1	1	0	0	0	0	0	0
Depreciation	3	3	3	3	3	4	4	4
Profit before tax	6	15	13	15	20	18	17	19
Tax %	21%	21%	27%	25%	26%	26%	24%	—
Net Profit	5	12	9	11	14	13	13	14
EPS in Rs	3.87	9.44	7.49	9.21	11.78	10.86	10.65	11.78
Dividend Payout %	32%	0%	0%	0%	0%	0%	0%	—

PAR balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4	6	6	12	12	12	12	12
Reserves	25	34	46	48	59	73	87	100
Borrowings	12	6	8	0	0	0	0	0
Other Liabilities	11	13	16	19	18	16	20	17
Total Liabilities	51	60	76	79	89	102	119	129
Fixed Assets	36	34	30	34	38	41	39	36
CWIP	0	1	5	0	0	0	0	1
Investments	0	0	0	0	0	0	25	27
Other Assets	15	25	42	44	50	60	55	65
Total Assets	51	60	76	79	89	102	119	129

PAR cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	2	8	12	8	13	20	16	16
Cash from Investing Activity	-0	-1	0	-3	-7	-6	-25	-2
Cash from Financing Activity	-2	1	2	-10	0	0	0	0
Net Cash Flow	-0	7	14	-5	6	14	-9	14
Free Cash Flow	2	6	12	4	6	14	15	14
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	34%	90%	98%	66%	97%	108%	106%	125%

PAR shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	73.37%	73.37%	73.37%	73.37%	73.41%	73.41%	73.41%	73.41%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.09%	0.09%
Public	26.63%	26.63%	26.63%	26.63%	26.59%	26.59%	26.51%	26.51%
No. of Shareholders	17,189	15,472	14,887	14,280	13,761	13,222	12,782	12,672

PAR key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	67	81	75	90	65	52	60	42
Inventory Days	81	45	50	60	49	45	58	45
Days Payable	94	96	112	135	73	58	104	69
Cash Conversion Cycle	55	30	13	14	40	40	15	19
Working Capital Days	13	39	24	61	50	40	39	31
ROCE %	12%	16%	25%	22%	23%	25%	18%	15%

PARUpdated 18 Oct 2026, 8:26

Par Drugs And Chem Ltd

PARUpdated 18 Oct 2026, 8:26

Market Cap

₹135Cr.

Current Price

₹110

High / Low

₹180/78.0

Stock P/E

9.30

ROE9.95%

ROCE14.6%

Book Value₹91.0

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	22.93	0.02	18.79	0.01	0.83	3.3	25.15	2.47	2.01
Sep 2023	25.89	0.03	18.53	0.05	0.85	6.53	25.27	4.89	3.97
Dec 2023	24	0.02	18.77	0.23	0.87	4.57	25.16	3.42	2.78
Mar 2024	22.82	0.05	16.72	-0.05	0.89	5.11	27.2	3.72	3.02
Jun 2024	22.61	0.02	18.37	0.07	0.9	3.39	25.07	2.53	2.06
Sep 2024	34.66	0.03	23.25	1.02	0.91	11.49	25.15	8.6	6.99
Dec 2024	21.38	0.01	19.95	0.27	0.91	0.78	24.36	0.58	0.47
Mar 2025	22.33	0.02	19.9	0.79	0.92	2.28	27.63	1.65	1.34
Jun 2025	26.05	0.02	22.49	1.84	0.9	4.48	25.67	3.33	2.71
Sep 2025	28.66	0.05	22.6	0.48	0.94	5.55	25.59	4.13	3.36
Dec 2025	29.34	0.01	23.29	1.33	0.93	6.44	25.47	4.8	3.9
Mar 2026	19.61	0.04	18.17	0.36	0.93	0.83	-3.61	0.85	0.69
Jun 2026	31.28	0.02	24.91	0.94	0.96	6.33	25.59	4.71	3.83

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	33	4	26	0	2	1	27	1	1.65
Mar 2016	33	4	26	0	3	1	58	0	0.78
Mar 2017	49	2	40	0	3	3	42	2	3.43
Mar 2018	42	2	34	0	3	3	42	2	2.78
Mar 2019	46	2	38	0	3	3	24	3	2.79
Mar 2020	56	1	46	0	3	6	21	5	3.87
Mar 2021	61	1	45	2	3	15	21	12	9.44
Mar 2022	75	0	59	0	3	13	27	9	7.49
Mar 2023	96	0	78	0	3	15	25	11	9.21
Mar 2024	96	0	73	0	3	20	26	14	11.78
Mar 2025	101	0	81	2	4	18	26	13	10.86
Mar 2026	104	0	87	4	4	17	24	13	10.65
TTM	109	0	89	3	4	19	—	14	11.78

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	73.41%
DIIs	0.09%
Public	26.51%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	74.21%	0.07%	0%	25.73%
Mar 2024	74.21%	0.07%	0.05%	25.68%
Jun 2024	74.21%	0.32%	0%	25.47%
Sep 2024	73.37%	0.09%	0%	26.54%
Dec 2024	73.37%	0%	0%	26.63%
Mar 2025	73.37%	0%	0%	26.63%
Jun 2025	73.37%	0%	0%	26.63%
Sep 2025	73.37%	0%	0%	26.63%
Dec 2025	73.41%	0%	0%	26.59%
Mar 2026	73.41%	0%	0%	26.59%
Jun 2026	73.41%	0%	0.09%	26.51%
Sep 2026	73.41%	0%	0.09%	26.51%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	3	9	38	9	59	45	0	0	13	59
Mar 2016	3	9	36	10	58	43	0	0	15	58
Mar 2017	3	11	31	12	56	42	0	0	14	56
Mar 2018	3	12	29	10	54	39	0	0	15	54
Mar 2019	4	25	12	11	51	36	0	0	15	51
Mar 2020	6	34	6	13	60	34	1	0	25	60
Mar 2021	6	46	8	16	76	30	5	0	42	76
Mar 2022	12	48	0	19	79	34	0	0	44	79
Mar 2023	12	59	0	18	89	38	0	0	50	89
Mar 2024	12	73	0	16	102	41	0	0	60	102
Mar 2025	12	87	0	20	119	39	0	25	55	119
Mar 2026	12	100	0	17	129	36	1	27	65	129

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	9	0	-9	-1
Mar 2016	7	0	-5	1
Mar 2017	9	-2	-8	-1
Mar 2018	4	-1	-4	0
Mar 2019	2	0	-2	0
Mar 2020	8	-1	1	7
Mar 2021	12	0	2	14
Mar 2022	8	-3	-10	-5
Mar 2023	13	-7	0	6
Mar 2024	20	-6	0	14
Mar 2025	16	-25	0	-9
Mar 2026	16	-2	0	14

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	83	81	61	75	67	81	75	90	65	52	60	42
Inventory Days	111	158	69	83	81	45	50	60	49	45	58	45
Days Payable	184	183	135	107	94	96	112	135	73	58	104	69
Cash Conversion Cycle	10	57	-5	51	55	30	13	14	40	40	15	19
Working Capital Days	61	66	-46	-26	13	39	24	61	50	40	39	31
ROCE %	10%	9%	12%	11%	12%	16%	25%	22%	23%	25%	18%	15%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of PAR DRUGS AND CHEM LTD (PAR)?

The reported market capitalisation for PAR DRUGS AND CHEM LTD (PAR) is ₹135Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of PAR?

The current price shown for PAR DRUGS AND CHEM LTD (PAR) on Fincrux is ₹110 with a 52-week high/low of ₹180/78.0.

What is the P/E ratio of PAR DRUGS AND CHEM LTD (PAR)?

The stock P/E for PAR DRUGS AND CHEM LTD (PAR) is 9.30 on Fincrux, with ROE at 9.95% and ROCE at 14.6%.

What were PAR latest quarterly results?

For Jun 2026, PAR DRUGS AND CHEM LTD (PAR) reported sales ₹31.28 Cr and net profit ₹4.71 Cr (figures in ₹ crore unless noted).

What are PAR annual sales and net profit?

For TTM, PAR DRUGS AND CHEM LTD (PAR) shows sales of ₹109 Cr and net profit of ₹14 Cr on the Fincrux profit & loss statement.

Who owns PAR DRUGS AND CHEM LTD (PAR)?

Latest shareholding for PAR DRUGS AND CHEM LTD (PAR) on Fincrux: Promoters 73.41% (Sep 2026), FIIs 0.00% (Sep 2026), DIIs 0.09% (Sep 2026), Public 26.51% (Sep 2026), No. of Shareholders 12,672% (Sep 2026).

Where can I find PAR DRUGS AND CHEM LTD (PAR) financials?

PAR DRUGS AND CHEM LTD (PAR) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show PAR balance sheet and cash flow?

Yes. The PAR DRUGS AND CHEM LTD (PAR) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 8:26